Ritonavir

This page contains recent news articles, when available, and an overview of Ritonavir but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Ritonavir
(when available)

Pharmacology and use:
Ritonavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Ritonavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.

Mechanism Of Action:
Ritonavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles.

News Articles on Ritonavir

Prezista® 300 mg en rupture de stock  -  05 Jan 2010
...y compris les patients lourdement prétraités (posologie adulte : 600 mg/100 mg ritonavir x 2 fois/jour), et chez les enfants et adolescents prétraités, ... ARCAT

Does Switching to Norvir-Boosted Reyataz Spare the Heart?  -  ‎Dec 31, 2009‎
Most had been on Kaletra (lopinavir plus ritonavir). Twenty-four weeks into the study, people who switched to Norvir-boosted Reyataz saw significant ... AIDSmeds.com HIV/AIDS Treatment News

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy ...  -  ‎Dec 23, 2009‎
Different strategies of ritonavir-boosted lopinavir monotherapy have been explored; however, data regarding salvage therapy among HIV-infected patients who ... 7thSpace Interactive (press release)

Hepatic profile analyses of tipranavir in Phase II and III clinical trials  -  ‎Dec 15, 2009‎
The risk and course of serum transaminase elevations (TEs) and clinical hepatic serious adverse event (SAE) development in ritonavir-boosted tipranavir ... 7thSpace Interactive (press release)

With Poor Adherence, PIs Might Have an Advantage Over NNRTIs  -  ‎Dec 29, 2009‎
People taking a protease inhibitor without low-dose Norvir (ritonavir) were also more likely to develop drug resistance with poorer adherence than those who ... AIDSmeds.com HIV/AIDS Treatment News

UNITAID approves patent pool for HIV drugs  -  ‎Dec 15, 2009‎
Merck, as well as Sequoia, a biotechnology company that is developing an agent that could replace ritonavir as a booster for protease inhibitors. ... Aidsmap

• Pharmacological class: Kinase inhibitor  -  ‎Dec 12, 2009‎
Concomitant strong CYP3A4 inhibitors (eg, ketoconazole, ritonavir, clarithromycin): avoid; if warranted, reduce dose of pazopanib to 400mg; ... American Journal of Hemotology and Oncology

Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and ...  -  ‎Dec 26, 2009‎
LIVALO has not been studied with the protease inhibitor combination lopinavir/ritonavir. LIVALO should not be used with this combination of protease ... AUTO-MOBI.info

Study Identifies Viread And Emtriva As The Preferred Initial Treatment For HIV ...  -  ‎Dec 10, 2009‎
The patients were divided into four groups who received Viread and Emtriva or Ziagen and Epivir along with either Norvir (ritonavir)-boosted Reyataz ... The AIDS Beacon (blog)

Favorable Vote from FDA Advisory Committee on Benefit/Risk of CRESTOR(R ...  -  ‎Dec 15, 2009‎
...increased with concurrent administration of some other lipid-lowering therapies (fibrates or niacin), gemfibrozil, cyclosporine, or lopinavir/ritonavir. ... CNNMoney.com (press release)

Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA ...  -  ‎Dec 11, 2009‎
...increased with concurrent administration of some other lipid-lowering therapies (fibrates or niacin), gemfibrozil, cyclosporine, or lopinavir/ritonavir. ... CNNMoney.com (press release)

Haciendo que los fármacos sobrevivan más tiempo en la sangre  -  ‎Dec 18, 2009‎
Por tanto hay que suministrar un segundo fármaco, ritonavir, que inhibe la función de esas enzimas metabolizantes. Sin embargo, y puesto que las mismas ... AlianzaTex

Ð?нтиретровируÑ?ный режим показал выÑ?окую Ñ?ффективноÑ?ть у больных ...  -  ‎Dec 14, 2009‎
High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/ Ritonavir among Treatment-Experienced Patients Infected with ... Medicus Amicus

FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to ...  -  ‎Nov 5, 2009‎
Four hundred and forty patients were randomized to receive REYATAZ 300 mg and ritonavir 100 mg once daily and 443 patients were randomized to receive ... WELT ONLINE

UPDATE 1-Once-daily Schering hepatitis C drug shows promise  -  ‎Nov 2, 2009‎
They then added narlaprevir to their drug regimen, along with a low-dosage form of a widely used medicine for HIV called ritonavir meant to slow down the ... Reuters

Concert Starts HIV Trial, Bags $12M From Glaxo to Help Challenge Gilead's Once ...  -  ‎Nov 9, 2009‎
That's desirable because it could allow doctors to quit prescribing a booster drug from Abbott Laboratories called ritonavir that adds cost, complexity, ... Xconomy

Prezista monotherapy shows similar efficacy and safety as combination therapy  -  ‎Nov 13, 2009‎
For treatment-experienced adult patients, the current licensed dosing for darunavir is 600mg taken with 100 mg ritonavir twice daily with food in ... Pharmacy Europe

AASLD: Once-Daily HCV Protease Inhibitors Show Early Promise  -  ‎Nov 3, 2009‎
In the current study, called NEXT-1, several permutations of the narlaprevir-ritonavir and interferon-ribavirin combinations are being tested. ... MedPage Today

Concert: protease inhibitor holds potential to be prescribed un-boosted  -  ‎Nov 10, 2009‎
Early data on the candidate suggest that, unlike many marketed protease inhibitors, it does not require ritonavir boosting. Datamonitor believes that if ... Trading Markets (press release)

Concert Pharmaceuticals Initiates Phase 1b Clinical Trial Of CTP-518, Protease ...  -  ‎Nov 11, 2009‎
..."Ritonavir co-administration is currently recommended for all marketed HIV protease inhibitors. Our goal is to provide patients with a potent and ... Medical News Today (press release)

FDA OKs Labeling Update for Reyataz Capsules  -  ‎Nov 9, 2009‎
Four hundred and forty patients were randomized to receive Reyataz 300 mg and ritonavir 100 mg once daily and 443 patients were randomized to receive ... Trading Markets (press release)

InterMune, Inc. Q3 2009 Earnings Call Transcript  -  ‎Nov 10, 2009‎
Ritonavir is an antiviral compound commonly used at low doses to enhance or boost the pharmacokinetic profiles of protease inhibitors. ... Seeking Alpha (blog)

Darunavir/ritonavir, etravirine and raltegravir has 'remarkable' success in ...  -  ‎Oct 29, 2009‎
A combination of darunavir/ritonavir, etravirine, and raltegravir is “remarkably� effective in HIV-positive adolescents with extensive prior experience of ... Aidsmap

Scientists Reveal A New Mechanism That Increases Atherosclerosis In Mice  -  ‎Nov 6, 2009‎
...the antiretroviral drug ritonavir for HIV treatment and the antiepileptic drugs carbamazipine and phenobarbital, all of which activate PXR. ... Science Daily (press release)

Dietary Supplements May Increase Longevity Of HIV Patients  -  ‎Nov 8, 2009‎
According to the National Institute of Health, garlic supplements may adversely react with ritonavir (Norvir) and increase levels of this drug in the body. ... The AIDS Beacon (blog)

Lower Norvir Boosting Dose Possible  -  ‎Oct 29, 2009‎
Hill and his colleagues also looked at studies with lopinavir (combined with ritonavir in Kaletra), Reyataz (atazanavir), Crixivan (indinavir) and Aptivus ... AIDSmeds.com HIV/AIDS Treatment News

Post-Exposure Prophylaxis of HIV Transmission Spotlighted Case vignette of ...  -  ‎Oct 28, 2009‎
...we would recommend a 28-day course of tenofovir plus emtricitabine with or without a boosted protease inhibitor such as ritonavir-lopinavir; however, ... ModernMedicine

What Risks Are Associated With High-Dose Rosuvastatin?  -  ‎Oct 22, 2009‎
...dose of 5 mg is recommended for patients of Asian ethnicity, patients with severe renal impairment, and patients taking concomitant lopinavir/ritonavir. ... Medscape

Doc Offers Top Hep C Drug Picks: BioBuzz  -  ‎Nov 9, 2009‎
...on Schering-Plough's(SGP Quote) second-generation protease inhibitor narlaprevir, which uses a common HIV drug known as ritonavir to boost blood levels. ... TheStreet.com

Gilead Sciences, Inc. Q3 2009 Earnings Call Transcript  -  ‎Oct 20, 2009‎
These are important data as they supported a Phase II study design of GS 9350 versus Ritonavir in combination with Atazanavir and Truvada in HIV-infected ... Seeking Alpha (blog)

InterMune Reports Third Quarter 2009 Financial Results and Business Highlights  -  ‎Nov 5, 2009‎
Ritonavir is an antiviral compound commonly used at low doses to enhance or "boost" the pharmacokinetic (PK) profiles of protease inhibitors. ... Reuters

Schering-Plough reports encouraging results from Phase IIa hepatitis study  -  ‎Nov 4, 2009‎
The Next-1 study evaluates 12 weeks of narlaprevir 200mg or 400mg once-daily or 100mg twice daily with low-dose ritonavir (100mg) in combination with ... Trading Markets (press release)

New mechanism apparently increases atherosclerosis in mice  -  ‎Nov 9, 2009‎
Supposedly, these drugs include the antibiotic rifampicin taken for tuberculosis treatment, the antiretroviral drug ritonavir for HIV treatment and the ... HealthJockey.com

FDA Safety Changes: DepoDur, Neoral, Lexiva  -  ‎Nov 4, 2009‎
The FDA also warned that treatment with fosamprenavir and ritonavir has been linked to increases in triglyceride and cholesterol levels. ... Medscape

FDA Sends Letter to Sanofi-Aventis Regarding Uroxatral Promotion  -  ‎Oct 28, 2009‎
...in patients with moderate or severe hepatic impairment and co-administration with potent CYP3A4 inhibitors (eg, ketoconazole, itraconazole, ritonavir). ... PharmaLive.com (press release)

Market Watch  -  ‎Nov 5, 2009‎
...nefazodone, nelfinavir, ritonavir, saquinavir, or telithromycin). The most common adverse effects in clinical trials were respiratory tract infection, ... The Hospitalist Online

New drug for type 2 diabetes  -  ‎Oct 29, 2009‎
...nelfinavir, ritonavir, saquinavir, telithromycin). Concomitant sulfonylurea: may need lower dose of sulfonylurea to reduce risk of hypoglycemia. ... Clinical Advisor

How antiretroviral therapy prolongs life  -  ‎Oct 21, 2009‎
...ritonavir and nelfinavir prevent the cutting of the precursor polypeptide that is processed into smaller core proteins. l Entry inhibitors: these drugs ... The Southern Times

Prezista accepted for use by NHS Scotland  -  ‎Oct 21, 2009‎
Darunavir 800mg should be taken once daily with low dose ritonavir and with food as part of combination therapy. "Once daily Darunavir is a welcome addition ... Hospital Healthcare Europe

Don't drink and braai  -  ‎Oct 21, 2009‎
Studies have shown that those who smoke have an 18% reduction in their blood levels of ritonavir, an ARV that belongs to the class of protease inhibitors. ... The Southern Times

Canada approves ISENTRESS(R) for adults starting HIV treatment  -  ‎Oct 20, 2009‎
Raltegravir does not require boosting with ritonavir. - As of June 2006, 61423 people in Canada have tested positive for HIV. Of these people, 83.6% are ... CNW Telbec (Communiqué de presse)

El 37% de los españoles infectados por el VIH es diagnosticado tarde  -  ‎Oct 21, 2009‎
Por un lado, un estudio liderado por investigadores españoles (José Ramón Arribas y Federico Pulido Ortega) indica que lopinavir-ritonavir es una opción ... elmundo.es

Neu auf dem Markt  -  ‎Nov 3, 2009‎
...seiner Wirkung bei gleichzeitiger Einnahme von CYP3A4-Induktoren wie Rifampicin, Phenytoin, Carbamazepin, Ritonavir und Johanniskraut vermutet. ... Pharmazeutische Zeitung online

El diagnóstico precoz y los nuevos fármacos contra el VIH/Sida, temas clave ...  -  ‎Oct 21, 2009‎
En este campo, se presentarán datos del mayor estudio de pacientes en tratamiento con lopinavir/ritonavir en monoterapia, que demuestra que es una opción ... Europa Press

Le Canada approuve ISENTRESS(MC) pour les adultes commençant un traitement ...  -  ‎Oct 20, 2009‎
Le raltégravir n'a pas besoin d'être renforcé à l'aide de ritonavir. À propos du VIH-SIDA - En date de juin 2006, 61 423 personnes avaient eu un test ... CNW Telbec (Communiqué de presse)

Glaxo says FDA OKs use of HIV drug Lexiva with ritonavir  -  Oct 12, 2007
Oct 12 (Reuters) - GlaxoSmithKline (GSK.N) said US health regulators approved the use of HIV protease inhibitor Lexiva in combination with 100mg of ... Reuters

Darunavir/ritonavir superior virologically and immunologically to …  -  Aug 15, 2006
The boosted protease inhibitor darunavir/ritonavir (formerly TMC114/r and licensed as Prezista in the United States) provides superior suppression of HIV ... Aidsmap

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Sep 30, 2008
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Sep 30, 2008
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

Effect of low-dose ritonavir (100 mg twice daily) on the activity of ...  -  Mar 25, 2005
Correspondence: Rob E. Aarnoutse, PharmD, PhD, Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, PO Box 9101, 533 KF, 6500 HB, ... Nature.com

New drug for HIV 'shows promise'  -  Apr 4, 2007
Almost half (45%) of those taking darunavir-ritonavir reduced their HIV RNA concentrations to below 50 copies per ml of blood - the lowest recordable value. ... BBC News

Oral solution of tipranavir/ritonavir shows promise for treatment- …  -  Aug 17, 2006
An investigational oral solution of the protease inhibitor tipranavir (Aptivus), boosted by ritonavir, has a potent anti-HIV effect and is generally well ... Aidsmap

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Sep 30, 2008
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

… with concurrent administration of rifabutin and lopinavir/ritonavir...  -  Oct 26, 2007
Ritonavir is a potent inhibitor of CYP3A4 and has been shown to substantially ... Co-administration of rifabutin with ritonavir increased area under the ... Nature.com

Once-Daily Combo Works for New HIV Patients  -  Aug 4, 2008
1 (HealthDay News) -- Once-daily treatment with atazanavir/ritonavir (A/R) is as effective ... "In treatment-naive patients, atazanavir/ritonavir once-daily ... Washington Post

New Combo Drug Therapies Prove Effective Against HIV  -  Jul 5, 2007
Forty-eight weeks into treatment, 77 percent of patients taking a darunavir-ritonavir combo had significantly lowered HIV viral load, compared to 68 percent ... Washington Post

Longtime Expert on ALS Now Knows It All Too Well  -  Feb 22, 2005
One, Ritonavir, is used to treat HIV patients; the other, hydroxyurea, is used in leukemia and sickle cell anemia. Since the drugs are available for other ... New York Times

CROI: New Integrase Drugs Take Aim at Essential HIV Target  -  Feb 9, 2006
He noted that ritonavir allows GS9137 to remain in the bloodstream up to nine hours. Future studies of GS9137 will include ritonavir boosting, he said. ... CNN

Impact of Different Low-Dose Ritonavir Regimens on Lipids, CD36, and ...  -  Aug 7, 2008
We investigated the relationship between ritonavir concentrations and changes in lipids, vascular inflammation markers, CD36, and adipophilin expression in ... Nature.com

Pharmacokinetics and Safety of Saquinavir/Ritonavir and Omeprazole in...  -  Feb 5, 2007
We investigated the pharmacokinetics and safety of saquinavir/ritonavir when administered with omeprazole simultaneously and 2 h apart to human ... Nature.com

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Oct 24, 2006
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

FDA Approves New HIV Drug  -  Jun 24, 2005
Aptivus should be given with another drug, Norvir (ritonavir) to treat HIV-infected adults, according to an FDA news release. When used with Norvir, ... FOXNews

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Sep 30, 2008
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

Lopinavir and Ritonavir (Systemic ).  -  Feb 1, 2006
The combination of lopinavir and ritonavir (low-PIN-a-veer and ri-TOE-na-veer) is used in the treatment of the infection caused by the human ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Boehringer's Tipranavir gets approval recommendation from FDA …  -  May 20, 2005
Tipranavir is a non-peptidic protease inhibitor that requires boosting with low-dose ritonavir and must be used in combination with other antiretroviral ... Forbes

New Prezista(R) Phase 3 Study Meets Primary Objective of Non-  -  Jul 6, 2007
Prezista, co-administered with low dose ritonavir (r), is indicated in combination with other antiretroviral medicinal products for the treatment of human ... BiznesNet

Dose–Response of Ritonavir on Hepatic CYP3A Activity and Elvitegravir...  -  Apr 22, 2008
Ritonavir, a potent inhibitor of cytochrome P450 isoform 3A (CYP3A) activity, is frequently used to boost the effects of protease inhibitors at doses of ... Nature.com

… Approval for New Kaletra(R) (Lopinavir/Ritonavir) Tablet Formulatio...  -  Oct 31, 2005
Kaletra(R) (lopinavir/ritonavir) is always used in combination with other ... They are lopinavir and ritonavir. Kaletra is a type of medicine called an HIV ... Free with registration - PR Newswire - AccessMyLibrary.com

Abbott Holds Back AIDS Drug  -  Jul 5, 2006
...“The result is that the new formulation of lopinavir/ritonavir remains unavailable and unaffordable for the vast majority of patients who need it,� said MSF ... Red Herring

… Plasma Trough Concentrations of Lopinavir and Ritonavir in HIV...  -  Sep 6, 2007
This is ascribed to a drug interaction, such that ritonavir by inhibiting ... In the clinical setting, where lopinavir and ritonavir are always combined, ... Nature.com

IAS: Virological failure rare in patients taking saquinavir / ritonavi...  -  Jul 30, 2005
This is similar to the situation for other ritonavir-boosted protease ... They conclude, “these results support the use of saquinavir / ritonavir in ... Aidsmap

Study Supports Popular HIV Drug Regimen  -  May 14, 2008
The virus gained a foothold in one-third of those who took lopinavir-ritonavir plus efavirenz -- two drugs instead of the usual three -- and in 27 percent ... Washington Post

Abbott Seeks Approval of Children's Dose HIV Drug  -  Jul 20, 2007
The lower-strength tablet contains 100 mg of lopinavir and 25 mg of ritonavir compared with the current tablet strength of 200 mg of lopinavir and 50 mg of ... TheStreet.com - TheStreet.com (subscription)

FDA approves new drug to combat HIV  -  Jun 24, 2006
Norvir, also called ritonavir, slows the metabolism of Prezista, boosting its effect. In return for the FDA's accelerated approval of the drug, ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette

US FDA expands approval for J&J HIV drug  -  Oct 22, 2008
Patients new to HIV therapy should take the drug with ritonavir and food to get ... Ritonavir, sold by Abbott Laboratories (ABT.N) under the name Norvir, ... Reuters

Dying doctor's noble choice Stricken SF neurologist enters own 'placeb...  -  Jan 17, 2005
He expects to be given either the AIDS drug, a protease inhibitor called ritonavir; or the cancer drug, hydroxyurea; or a placebo, starting in about two ... San Francisco Chronicle

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Sep 30, 2008
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

… Study Comparing Fosamprenavir to Lopinavir/Ritonavir Presented at...  -  Aug 17, 2006
TORONTO, CANADA -- August 17, 2006 -- This month, The Lancet published results of a study showing that HIV regimens using Lexiva (Telzir) Tablets+ritonavir ... DG News

Lopinavir/ritonavir tablets  -  Nov 1, 2005
This tablet formulation of lopinavir and ritonavir provides several advantages over the capsule formulation, including: a reduced pill burden of 4 tablets ... Free with registration - Formulary - AccessMyLibrary.com

China approves import of new anti-AIDS drug_English_Xinhua  -  Nov 24, 2007
Lopinavir/ritonavir, developed by US-based Abbott Laboratories, has been on the market in the United States, Japan and Europe, sources with China's State ... 新�网

A Low Dose of Ritonavir-Boosted Atazanavir Provides Adequate …  -  Aug 15, 2008
Several dose-finding studies of boosted protease inhibitors have demonstrated that doses lower than those recommended in Caucasian populations exhibit in ... Nature.com

Africa: Access Denied to Crucial New HIV/Aids Medicines  -  Mar 15, 2006
The drug lopinavir/ritonavir is a crucial component of antiretroviral therapy for patients that need to be switched to a newer ?second-line? treatment ... AllAfrica.com

FDA Approves New HIV Therapy, Aptivus Capsules with Ritonavir  -  Jun 27, 2005
The Food and Drug Administration (FDA) announced the approval of Aptivus (tipranavir) capsules, an HIV protease inhibitor, to be given with ritonavir for ... i-newswire.com

Boehringer Ingelheim launches HIV drug trial  -  May 10, 2007
...will compare the efficacy of Viramune with that of protease inhibitor treatment Atazanavir/Ritonavir, both in combination with HIV treatment Truvada. Forbes

Atazanvir/Ritonavir Monotherapy Maintains Viral Suppression in Pilot ...  -  Feb 8, 2006
By Ed Susman. DENVER, CO -- February 8, 2006 -- Results of a small pilot study show that patients infected with HIV maintained viral suppression with ... DG News

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Sep 30, 2008
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

… Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Riton...  -  Jul 11, 2005
Kaletra(R) (lopinavir/ritonavir) is always used in combination with other anti-HIV medicines to treat people with human immunodeficiency virus (HIV) ... Medical News Today - Medical News Today (press release)

Roche, Trimeris say anti-HIV drug Fuzeon reduces level of HIV virus...  -  Jul 23, 2007
...available for the treatment of HIV, while Darunavir is a commercially available, ritonavir-boosted protease inhibitor, marketed by Tibotec Therapeutics. Forbes

Lopinavir/ritonavir reduces lamotrigine plasma concentrations in...  -  Feb 14, 2006
Manon J. van der Lee, PharmD 1 , Lara Dawood 1 , Hadewych JM ter Hofstede, MD 1 , Marga JA de Graaff-Teulen 1 , Eleonora WJ van Ewijk-Beneken Kolmer 1 ... Nature.com

Lopinavir/ritonavir not linked to hepatotoxicity regardless of HCV...  -  Jan 25, 2005
Use of lopinavir/ritonavir (Kaletra) is not associated with significant liver toxicity even in patients coinfected with the hepatitis C virus (HCV), ... Aidsmap

ICAAC: Studies in ART-Naive and Experienced HIV Patients - Dr. Paul …  -  Oct 25, 2007
...[1] The efficacy of darunavir/ritonavir in patients with either extensive or more ... ARTEMIS evaluated an experimental darunavir/ritonavir dosing regimen, ... Medscape

Ritonavir Oral : Uses, Side Effects, Interactions, Pictures, Warnings...  -  Sep 30, 2008
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... WebMD

A press release distributed by PR Newswire Europe  -  Apr 4, 2006
Abbott plans to maintain its current lopinavir/ritonavir price of US$500 per ... By maintaining this price, lopinavir/ritonavir will continue to be one of ... prnewswire.co.uk

Low-dose ritonavir almost entirely responsible for lipid increases...  -  Nov 9, 2005
The lipid disturbances often observed in HIV-positive individuals prescribed lopinavir/ritonavir (Kaletra) are almost entirely caused by the 100mg ... Aidsmap

Interaction between lopinavir/ritonavir and warfarin.(Case study)  -  Aug 14, 2007
Drug interactions involving protease inhibitors are common. Protease inhibitors are well known inhibitors of the 3A4 isozyme of cytochrome P450. ... Free with registration - CMAJ: Canadian Medical Association... - AccessMyLibrary.com

Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower...  -  Jan 28, 2008
ABBOTT PARK, Ill., Jan. 28 /PRNewswire/ -- Abbott announced today that the European Committee for Medicinal Products for Human Use (CHMP), the scientific ... Free with registration - PR Newswire - AccessMyLibrary.com

Atazanavir/ritonavir as potent over two years as Kaletra, but has...  -  Mar 15, 2006
Atazanavir (Reyataz) with low dose ritonavir is as effective as Kaletra (lopinavir/ritonavir) at suppressing viral load over two years in ... Aidsmap

HIV/AIDS Therapy; Ritonavir has double-boosting function for both …  -  Feb 7, 2005
2005 FEB 7 - (NewsRx.com & NewsRx.net) -- Ritonavir has a double-boosting function for both lopinavir and saquinavir. According to a study from Spain, ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Ritonavir Oral : User Ratings covering uses, effectiveness, interactio...  -  Jul 31, 2008
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. ... WebMD

… To Expand Access And Affordability To Lopinavir/ritonavir In The...  -  Aug 20, 2006
Development of a new pediatric formulation of its lopinavir/ritonavir tablet to meet ... Lopinavir/ritonavir is a recommended second-line treatment for HIV ... Medical News Today - Medical News Today (press release)

Abbott and Government of Brazil Sign Kaletra® (lopinavir/ritonavir) …  -  Jul 7, 2007
...he Government of Brazil has accepted Abbott's offer to supply Kaletra® (lopinavir/ritonavir) tablets at the equivalent of US$1000 per patient per year in ... webwire.com

… Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir As...  -  Oct 28, 2008
PREZISTA must be co-administered with 100 mg ritonavir and food to achieve ... Failure to correctly administer PREZISTA with ritonavir and food may result ... Medical News Today - Medical News Today (press release)

Lopinavir-Ritonavir Tablets May Be Better Than Capsules  -  Jul 28, 2005
July 28, 2005 (Rio de Janeiro) -- A new formulation of lopinavir-ritonavir (Kaletra) as a tablet instead of the soft gel capsule or liquid preparation ... Medscape

Atazanavir/Ritonavir as Effective as Lopinavir/Ritonavir in HIV...  -  Aug 1, 2008
NEW YORK -- August 1, 2008 -- In HIV treatment-naïve patients, atazanavir/ritonavir (A/R) QD shows similar antiviral efficacy to lopinavir/ritonavir (L/R) ... DG News

Study Compares First-Line Drug Therapies For Treating HIV  -  Aug 8, 2006
The NRTI-sparing combination of lopinavir/ritonavir and efavirenz had never ... More participants in the lopinavir/ritonavir group experienced virologic ... newswise.com

Efavirenz May Be Best Initial Treatment of HIV-1 Infection  -  May 15, 2008
Lopinavir-ritonavir plus efavirenz had similar efficacy as efavirenz alone but ... In the efavirenz group and the lopinavir-ritonavir group, all patients ... Medscape

Cost Effectiveness of Lopinavir/Ritonavir Compared with Atazanavir...  -  Aug 10, 2007
Objective: To estimate the cost effectiveness and long-term combined effects of HIV disease and antiretroviral (ARV) therapy-related risk for coronary heart ... Medscape

Once-daily darunavir/ritonavir may be an option for some treatment- …  -  Oct 30, 2008
A once-daily dose of ritonavir-boosted darunavir (Prezista) may be an option for some treatment-experienced patients, according to a small study published ... Aidsmap

… HIV Positive Patients Treated With Combined Darunavir and Ritonavir...  -  Dec 14, 2006
...[Presentation title: Safety and Efficacy of Darunavir in Combination With Low-Dose Ritonavir: 48-Week Results From the POWER Studies. Abstract 74] DG News

… results when lopinavir and atazanavir are double-boosted with...  -  Jun 6, 2006
The double boosted combination of twice-daily lopinavir/ritonavir (Kaletra) with ... The use of double-boosted PIs - where low-dose ritonavir is utilised to ... Aidsmap

Ritonavir/Saquinavir plus Rifampicin in HIV Patients with Tuberculosis...  -  Oct 30, 2006
Objective: To assess the drug concentrations, efficacy and safety of concomitant use of rifampicin and regimens containing ritonavir/saquinavir (400mg/400mg ... Medscape

Price cuts for AIDS anti-retroviral drugs announced  -  Apr 28, 2008
...the reduction would be as much as 19 percent for the most frequently used second-line treatment such as tenofovir, lamivudine and lopinavir/ritonavir. ... Inquirer.net

In Brief / PHARMACEUTICALS; Warning issued for J&J drug  -  Mar 13, 2008
...though the problems have not been linked directly to Prezista, a protease inhibitor given in combination with Abbott Laboratories' ritonavir. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver

Darunavir/Ritonavir Achieves Superiority Over Lopinavir/Ritonavir in ...  -  Oct 28, 2008
By Ed Susman. WASHINGTON, DC -- October 28, 2008 -- Darunavir/ritonavir in combination with other anti-human immunodeficiency virus (HIV) drugs achieved ... DG News

Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance …  -  Aug 16, 2006
Susan Swindells, MBBS; A. Gregory DiRienzo, PhD; Timothy Wilkin, MD, MPH; Courtney V. Fletcher, PharmD; David M. Margolis, MD; Gary D. Thal, MD; ... Journal of American Medical Association - Journal of American Medical Association...

Lopinavir-Ritonavir Oral: Dosage, Uses and Warnings  -  Oct 24, 2006
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or ... Medscape

CROI: Atazanavir and atazanavir/ritonavir safe and effective in...  -  Feb 13, 2006
Atazanavir (Reyataz) boosted by ritonavir (Norvir) has a potent anti-HIV effect and is generally well tolerated when used to treat individuals who have ... Aidsmap

… welcomes decision by Abbott Labs to reduce price of lopinavir/riton...  -  Apr 11, 2007
In this context, WHO welcomes the decision of Abbott Laboratories to significantly reduce the price of lopinavir/ritonavir (LPV/r, ... News-Medical.net

CROI: Studies look at tipranavir/ritonavir's potency and pharmacokinet...  -  Mar 1, 2006
Blood samples from 39 patients taking tipranavir/ritonavir were obtained eleven to ... Higher mean trough concentrations of tipranavir and ritonavir were ... Aidsmap

Kaletra (Lopinavir/Ritonavir) Oral Solution - Healthcare Provider...  -  Aug 14, 2007
BETHESDA, MD -- August 14, 2007 -- Abbott Laboratories disseminated a Dear Healthcare Provider Letter throughout the world to physicians and pharmacists ... DG News

FDA Approves Abbott's Kaletra for Pediatric Patients  -  Nov 13, 2007
The pediatric dose of Kaletra (lopinavir/ritonavir) will offer more dosing flexibility and contain 100 mg of lopinavir and 25 mg of ritonavir compared with ... FDA news - FDA news (subscription)

HIV/AIDS HAART; Lopinavir/ritonavir is safe and effective in pretreate...  -  Jan 2, 2006
2006 JAN 2 - (NewsRx.com) -- Lopinavir/ritonavir is safe and effective in heavily pretreated HIV-infected children. According to recent research from Spain, ... Pay-Per-View - Anti-Infectives Week - Factiva, from Dow Jones

FDA notifications  -  Nov 1, 2005
Ritonavir concentrations obtained after 350 to 400 mg/m2 twice daily in ... The following observations were seen regarding ritonavir concentrations after ... Pay-Per-View - AIDS Alert - Factiva, from Dow Jones

RITONAVIR (Oral route) - ri-TOE-na-veer.(Drug overview)  -  May 1, 2007
Co-administration of ritonavir with certain nonsedating antihistamines, sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations may result in ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Heat-stable ritonavir tablet equivalent to soft gel capsule; may be …  -  Aug 15, 2008
A new 100 mg tablet formulation of the protease inhibitor ritonavir (Norvir) appears to be equivalent to the current soft-gel capsule formation in terms of ... Aidsmap

Abbott sued on ritonavir price increase  -  Jun 28, 2007
By Bob Roehr. The pharmaceutical company Abbott kicked off a storm of protest when it increased the price of the anti-HIV drug ritonavir (Norvir) by 400 ... pride source.com

Efavirenz superior to lopinavir/ritonavir in very advanced HIV,...  -  Aug 6, 2008
Efavirenz treatment results in a significantly higher rate of viral suppression after 48 weeks when compared to lopinavir/ritonavir, investigators of a ... Aidsmap

New Abbott Aluvia® Tablet for Treatment of HIV Available in South...  -  Jun 2, 2008
The lopinavir/ritonavir tablet (marketed as Aluvia in the developing world) is ... Each Aluvia tablet contains 200 mg of lopinavir and 50 mg of ritonavir. ... AllAfrica.com

… /Ritonavir Combination Continues to Show Superiority Over Ritonavir...  -  Sep 30, 2006
By Paula Moyer. SAN FRANCISCO, CA -- September 30, 2006 -- Patients with HIV who have undergone multiple regimens of antiretroviral therapy (ART) continue ... DG News

Learn about Lopinavir and Ritonavir from Consumer Reports Health.  -  Jan 9, 2007
The combination of lopinavir and ritonavir is used with other antiviral medications to treat human immunodeficiency virus (HIV) in patients with acquired ... consumerreports.org

Glaxo HIV drug performs well in study  -  May 16, 2006
...milligrams of Lexiva in combination with 100 milligrams of ritonavir, an HIV-suppressing ingredient in Kaletra, were able to combat viral replication. ... Bizjournals.com

… tablet formulation of Kaletra (lopinavir/ritonavir) receives...  -  Apr 28, 2006
The new formulation of Kaletra will provide patients with a tablet composed of 200 mg lopinavir and 50 mg ritonavir, as compared to the current soft capsule ... Pay-Per-View - Company Reports - Factiva, from Dow Jones

Severe interaction between low-dose ritonavir and a blood pressure...  -  Dec 12, 2006
A severe interaction between the ritonavir component of Kaletra (lopinavir/ritonavir) and the anti-hypertensive drug, nifedipine, has been reported. ... Aidsmap

… continues over interaction between ritonavir-boosted atazanavir...  -  Mar 22, 2006
Three letters published in the March edition of The Journal of Acquired Immune Deficiency Syndromes have illustrated that there is still considerable ... Aidsmap

Alopecia induced by lopinavir plus ritonavir therapy in an HIV...  -  Jul 1, 2007
The most commonly reported side effects related to lopinavir/ritonavir are diarrhea, vomiting, headache, nausea, and increased serum triglycerides and ... $4.95 - Journal of Drugs in Dermatology - ECNext

Long-Term Data Show Aptivus(R) (tipranavir) Continues to Outperform …  -  Nov 12, 2006
The tolerability profile of tipranavir/r was similar to that of other ritonavir-boosted protease inhibitors. Gastrointestinal symptom disorders and elevated ... presseportal.de

New AIDS drugs bests Kaletra  -  Jul 25, 2007
The drugs, both boosted with doses of ritonavir, were used to treat patients who had previously been using other drugs to control infection with the human ... United Press International

Unexpected interaction between heroin substitute and atazanavir/ritona...  -  Mar 27, 2006
Atazanavir (Reyataz), boosted by low dose ritonavir (Norvir) appears to interact with the ... Three cases of an interaction between atazanavir/ritonavir and ... Aidsmap

HIV/AIDS Treatment; Invirase boosted with ritonavir not associated...  -  Aug 24, 2005
2005 AUG 24 - (NewsRx.com) -- Starting treatment of HIV infection with Roche's protease inhibitor Invirase (saquinavir mesylate) boosted with a small dose ... Pay-Per-View - Vaccine Weekly - Factiva, from Dow Jones

Boehringer Ingelheim Initiates SPRING Study of Aptivus(R) (tipranavir)...  -  Jun 14, 2007
The use of other active agents with APTIVUS/ritonavir is associated with a ... Use caution when prescribing APTIVUS/ritonavir in patients who may be at risk ... Free with registration - PR Newswire - AccessMyLibrary.com

Study Compares First-Line Drug Therapies For Treating HIV  -  Aug 20, 2006
The NRTI-sparing combination of lopinavir/ritonavir and efavirenz had never ... More participants in the lopinavir/ritonavir group experienced virologic ... Medical News Today - Medical News Today (press release)

Darunavir Not Inferior to Lopinavir in Treatment-Naive HIV Patients: ...  -  Sep 20, 2007
The use of darunavir/ritonavir in treatment-naive patients and the once-daily, ... Darunavir, coadministered with 100 mg of ritonavir and with other ... DG News

No Differences in Trial of Fosamprenavir/Ritonavir  -  Aug 21, 2006
August 21, 2006 (Toronto) — Data from a randomized 48-week study comparing fosamprenavir ( Lexiva, GlaxoSmithKline)/ritonavir (FPV/r) and ... Medscape

Tipranavir Oral Solution With Low-Dose Ritonavir Effective and Safe...  -  Aug 21, 2006
By Danny Kucharsky. TORONTO, CANADA -- August 21, 2006 -- Tipranavir oral solution with low-dose ritonavir shows clinically relevant virologic and ... DG News

EU commission approves Aptivus® for the treatment of HIV  -  Oct 26, 2005
The approved dose of Aptivus is 500 mg taken with 200 mg of ritonavir, twice daily. Co-administration with ritonavir is required and “boosts� the ... biotech-intelligence.com

Brand Names/Synonyms:
Ritonavir is also known by the following brand names and/or synonymsAbbott 84538; Kaletra; Norvir; Norvir Sec; Ritonavir; Ritonavir [Usan]

Drug Category:
Ritonavir is categorized under the following by the FDA: Anti-HIV Agents; HIV Protease Inhibitors; ATC:J05AE03

Dosage Forms:
CAPSULE (100 mg); SOLUTION (80 mg/mL of ritonavir)

Absorption:
The absolute bioavailability of ritonavir has not been determined.

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
1,3-thiazol-5-ylmethyl [3-hydroxy-5-[3-methyl-2-[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino-butanoyl]amino-1,6-diphenyl-hexan-2-yl]aminoformate





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy